Source: Investing.com ↗

An2 therapeutics director Robin Readnour sells $6,674 in shares

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

USDC/USDT

$1.00

-0.02%

BTC/USDT

$84,116.65

+4.66%

ETH/USDT

$2,704.77

+4.86%

NEAR/USDT

$4.33

+22.32%

ZEC/USDT

$1,515.36

+5.40%